A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
Clinical trial NCT04708470 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04708470
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-05
- Primary completion
- 2026-11-30
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.